Table 2.
Variable | All patients (n = 253) |
Tumor location* |
||
---|---|---|---|---|
Renal pelvis (n = 171) |
Ureter (n = 78) |
p value | ||
pT stage, No. (%) | ||||
pT0 | 4 (1.6) | - | - | - |
pTis | 11 (4) | 7 (4) | 4 (5) | 0.06 |
pTa | 70 (28) | 54 (31.6) | 16 (20.5) | - |
pT1 | 47 (19) | 31 (18) | 16 (20.5) | - |
pT2 | 56 (22) | 31 (18) | 25 (32) | - |
pT3 | 59 (23) | 42 (25) | 17 (22) | - |
pT4 | 6 (2.4) | 6 (3.5) | 0 (0) | - |
pN stage, No. (%) | ||||
Nx | 92 (36) | 62 (36) | 27 (35) | 0.91 |
N0 | 138 (55) | 94 (55) | 43 (55) | - |
N+ | 23 (9) | 15 (9) | 8 (10) | - |
Tumor grade, No. (%) | ||||
Low | 63 (25) | 41 (24) | 18 (23) | 1.0 |
High | 190 (75) | 130 (76) | 60 (77) | - |
Tumor focality, No. (%) | ||||
Unifocal | 189 (75) | 133 (78) | 52 (67) | 0.08 |
Multifocal | 64 (25) | 38 (22) | 26 (33) | - |
Concomitant CIS, No. (%) | ||||
No | 183 (72) | 130 (76) | 49 (63) | 0.04 |
Yes | 64 (25) | 41 (24) | 29 (37) | - |
CIS = carcinoma in situ.
*n = 4, pT0 patients (submitted to previous endoscopic tumor ablation).